Salivary	B:C0442040
protective	O
factors	O
in	O
patients	O
suffering	O
from	O
decompensated	O
type	O
2	I:C0011860
diabetes	I:C0011860
Defining	O
the	O
level	O
of	O
protective	O
factors	O
in	O
saliva	O
of	O
patients	O
suffering	O
from	O
decompensated	O
type	O
2	I:C0011860
diabetes	I:C0011860
.	O

Salivary	O
protective	O
factors	O
in	O
patients	O
suffering	O
from	O
decompensated	O
type	B:C0011860
2	I:C0011860
diabetes	I:C0011860
Defining	O
the	O
level	O
of	O
protective	O
factors	O
in	O
saliva	O
of	O
patients	O
suffering	O
from	O
decompensated	O
type	O
2	I:C0011860
diabetes	I:C0011860
.	O

Salivary	O
protective	O
factors	O
in	O
patients	O
suffering	O
from	O
decompensated	O
type	O
2	I:C0011860
diabetes	I:C0011860
Defining	O
the	O
level	O
of	O
protective	O
factors	O
in	O
saliva	B:C0036087
of	O
patients	O
suffering	O
from	O
decompensated	O
type	O
2	I:C0011860
diabetes	I:C0011860
.	O

Salivary	O
protective	O
factors	O
in	O
patients	O
suffering	O
from	O
decompensated	O
type	O
2	I:C0011860
diabetes	I:C0011860
Defining	O
the	O
level	O
of	O
protective	O
factors	O
in	O
saliva	O
of	O
patients	O
suffering	O
from	O
decompensated	O
type	B:C0011860
2	I:C0011860
diabetes	I:C0011860
.	O

50	O
Patients	O
with	O
diagnosis	B:C0011900
of	O
decompensated	O
type	O
2	I:C0011860
diabetes	I:C0011860
,	O
including	O
32	O
women	O
and	O
18	O
men	O
at	O
the	O
age	O
of	O
57.9	O
±9.2	O
years	O
.	O

50	O
Patients	O
with	O
diagnosis	O
of	O
decompensated	O
type	B:C0011860
2	I:C0011860
diabetes	I:C0011860
,	O
including	O
32	O
women	O
and	O
18	O
men	O
at	O
the	O
age	O
of	O
57.9	O
±9.2	O
years	O
.	O

50	O
Patients	O
with	O
diagnosis	O
of	O
decompensated	O
type	O
2	I:C0011860
diabetes	I:C0011860
,	O
including	O
32	O
women	B:C0043210
and	O
18	O
men	O
at	O
the	O
age	O
of	O
57.9	O
±9.2	O
years	O
.	O

50	O
Patients	O
with	O
diagnosis	O
of	O
decompensated	O
type	O
2	I:C0011860
diabetes	I:C0011860
,	O
including	O
32	O
women	O
and	O
18	O
men	B:C0025266
at	O
the	O
age	O
of	O
57.9	O
±9.2	O
years	O
.	O

The	O
control	O
group	O
consisted	O
of	O
50	O
people	B:C0027361
among	O
whom	O
there	O
were	O
38	O
women	O
and	O
12	O
men	O
whose	O
average	O
age	O
was	O
estimated	O
at	O
51.2±9.9	O
years	O
.	O

The	O
control	O
group	O
consisted	O
of	O
50	O
people	O
among	O
whom	O
there	O
were	O
38	O
women	B:C0043210
and	O
12	O
men	O
whose	O
average	O
age	O
was	O
estimated	O
at	O
51.2±9.9	O
years	O
.	O

The	O
control	O
group	O
consisted	O
of	O
50	O
people	O
among	O
whom	O
there	O
were	O
38	O
women	O
and	O
12	O
men	B:C0025266
whose	O
average	O
age	O
was	O
estimated	O
at	O
51.2±9.9	O
years	O
.	O

It	O
was	O
stated	O
the	O
increased	O
concentration	O
of	O
total	B:C1261360
protein	I:C1261360
by	O
60	O
%	O
and	O
decreased	O
concentration	O
of	O
IgA	O
by	O
70	O
%	O
,	O
of	O
lysozyme	O
by	O
27	O
%	O
and	O
of	O
lactoferrin	O
by	O
40	O
%	O
in	O
resting	O
saliva	O
of	O
patients	O
with	O
type	O
2	I:C0011860
diabetes	I:C0011860
if	O
compared	O
to	O
the	O
control	O
group	O
.	O

It	O
was	O
stated	O
the	O
increased	O
concentration	O
of	O
total	O
protein	I:C1261360
by	O
60	O
%	O
and	O
decreased	O
concentration	O
of	O
IgA	B:C0020835
by	O
70	O
%	O
,	O
of	O
lysozyme	O
by	O
27	O
%	O
and	O
of	O
lactoferrin	O
by	O
40	O
%	O
in	O
resting	O
saliva	O
of	O
patients	O
with	O
type	O
2	I:C0011860
diabetes	I:C0011860
if	O
compared	O
to	O
the	O
control	O
group	O
.	O

It	O
was	O
stated	O
the	O
increased	O
concentration	O
of	O
total	O
protein	I:C1261360
by	O
60	O
%	O
and	O
decreased	O
concentration	O
of	O
IgA	O
by	O
70	O
%	O
,	O
of	O
lysozyme	B:C3541379
by	O
27	O
%	O
and	O
of	O
lactoferrin	O
by	O
40	O
%	O
in	O
resting	O
saliva	O
of	O
patients	O
with	O
type	O
2	I:C0011860
diabetes	I:C0011860
if	O
compared	O
to	O
the	O
control	O
group	O
.	O

It	O
was	O
stated	O
the	O
increased	O
concentration	O
of	O
total	O
protein	I:C1261360
by	O
60	O
%	O
and	O
decreased	O
concentration	O
of	O
IgA	O
by	O
70	O
%	O
,	O
of	O
lysozyme	O
by	O
27	O
%	O
and	O
of	O
lactoferrin	B:C0022942
by	O
40	O
%	O
in	O
resting	O
saliva	O
of	O
patients	O
with	O
type	O
2	I:C0011860
diabetes	I:C0011860
if	O
compared	O
to	O
the	O
control	O
group	O
.	O

It	O
was	O
stated	O
the	O
increased	O
concentration	O
of	O
total	O
protein	I:C1261360
by	O
60	O
%	O
and	O
decreased	O
concentration	O
of	O
IgA	O
by	O
70	O
%	O
,	O
of	O
lysozyme	O
by	O
27	O
%	O
and	O
of	O
lactoferrin	O
by	O
40	O
%	O
in	O
resting	O
saliva	B:C0036087
of	O
patients	O
with	O
type	O
2	I:C0011860
diabetes	I:C0011860
if	O
compared	O
to	O
the	O
control	O
group	O
.	O

It	O
was	O
stated	O
the	O
increased	O
concentration	O
of	O
total	O
protein	I:C1261360
by	O
60	O
%	O
and	O
decreased	O
concentration	O
of	O
IgA	O
by	O
70	O
%	O
,	O
of	O
lysozyme	O
by	O
27	O
%	O
and	O
of	O
lactoferrin	O
by	O
40	O
%	O
in	O
resting	O
saliva	O
of	O
patients	O
with	O
type	B:C0011860
2	I:C0011860
diabetes	I:C0011860
if	O
compared	O
to	O
the	O
control	O
group	O
.	O

The	O
evaluation	B:C0220825
of	O
dependences	O
between	O
the	O
analyzed	O
protective	O
factors	O
and	O
the	O
indicator	O
of	O
oral	O
cavity	O
condition	O
proved	O
the	O
positive	O
correlation	O
between	O
the	O
concentration	O
of	O
total	O
protein	I:C0555903
and	O
the	O
number	O
of	O
DMFT	O
(	O
i.e.	O
the	O
rate	O
of	O
caries	O
intensity	O
)	O
.	O

The	O
evaluation	O
of	O
dependences	O
between	O
the	O
analyzed	O
protective	O
factors	O
and	O
the	O
indicator	O
of	O
oral	O
cavity	O
condition	O
proved	O
the	O
positive	B:C1446409
correlation	O
between	O
the	O
concentration	O
of	O
total	O
protein	I:C0555903
and	O
the	O
number	O
of	O
DMFT	O
(	O
i.e.	O
the	O
rate	O
of	O
caries	O
intensity	O
)	O
.	O

The	O
evaluation	O
of	O
dependences	O
between	O
the	O
analyzed	O
protective	O
factors	O
and	O
the	O
indicator	O
of	O
oral	O
cavity	O
condition	O
proved	O
the	O
positive	O
correlation	O
between	O
the	O
concentration	O
of	O
total	B:C0555903
protein	I:C0555903
and	O
the	O
number	O
of	O
DMFT	O
(	O
i.e.	O
the	O
rate	O
of	O
caries	O
intensity	O
)	O
.	O

The	O
evaluation	O
of	O
dependences	O
between	O
the	O
analyzed	O
protective	O
factors	O
and	O
the	O
indicator	O
of	O
oral	O
cavity	O
condition	O
proved	O
the	O
positive	O
correlation	O
between	O
the	O
concentration	O
of	O
total	O
protein	I:C0555903
and	O
the	O
number	O
of	O
DMFT	B:C0086103
(	O
i.e.	O
the	O
rate	O
of	O
caries	O
intensity	O
)	O
.	O

The	O
evaluation	O
of	O
dependences	O
between	O
the	O
analyzed	O
protective	O
factors	O
and	O
the	O
indicator	O
of	O
oral	O
cavity	O
condition	O
proved	O
the	O
positive	O
correlation	O
between	O
the	O
concentration	O
of	O
total	O
protein	I:C0555903
and	O
the	O
number	O
of	O
DMFT	O
(	O
i.e.	O
the	O
rate	O
of	O
caries	B:C0011334
intensity	O
)	O
.	O

The	O
remaining	O
coefficients	O
of	O
correlation	O
being	O
evaluated	O
proved	O
to	O
be	O
negative	B:C0205160
and	O
statistically	O
meaningless	O
.	O

The	O
obtained	O
outcomes	O
prove	O
a	O
high	O
influence	O
of	O
proteins	B:C0033684
included	O
in	O
saliva	O
on	O
the	O
prevalence	O
and	O
development	O
of	O
caries	O
at	O
patients	O
with	O
decompensated	O
type	O
2	I:C0011860
diabetes	I:C0011860
.	O

The	O
obtained	O
outcomes	O
prove	O
a	O
high	O
influence	O
of	O
proteins	O
included	O
in	O
saliva	B:C0036087
on	O
the	O
prevalence	O
and	O
development	O
of	O
caries	O
at	O
patients	O
with	O
decompensated	O
type	O
2	I:C0011860
diabetes	I:C0011860
.	O

The	O
obtained	O
outcomes	O
prove	O
a	O
high	O
influence	O
of	O
proteins	O
included	O
in	O
saliva	O
on	O
the	O
prevalence	O
and	O
development	O
of	O
caries	B:C0011334
at	O
patients	O
with	O
decompensated	O
type	O
2	I:C0011860
diabetes	I:C0011860
.	O

The	O
obtained	O
outcomes	O
prove	O
a	O
high	O
influence	O
of	O
proteins	O
included	O
in	O
saliva	O
on	O
the	O
prevalence	O
and	O
development	O
of	O
caries	O
at	O
patients	O
with	O
decompensated	O
type	B:C0011860
2	I:C0011860
diabetes	I:C0011860
.	O

